| Literature DB >> 26756582 |
Jonas F Nawroth1, Jonathan R McDaniel2, Ashutosh Chilkoti2, Rainer Jordan1, Robert Luxenhofer1.
Abstract
The design of drug delivery systems capable of efficiently delivering poorly soluble drugs to target sites still remains a major challenge. Such materials require several different functionalities; typically, these materials should be biodegradable and nontoxic, nonimmunogenic, responsive to their environment, and soluble in aqueous solution while retaining the ability to solubilize hydrophobic drugs. Here, a polypeptide-polymer hybrid of elastin-like polypeptides (ELPs) and poly(2-oxazoline)s (POx) is reported. This paper describes the chemical synthesis, physical characteristics, and drug loading potential of these novel hybrid macromolecules. A novel method is introduced for terminal functionalization of POx with protected maleimide moieties. Following recovery of the maleimide group via a retro Diels-Alder reaction, the consecutive Michael addition of thiol-functionalized ELPs yields the desired protein-polymer conjugate. These conjugates form nanoparticles in aqueous solution capable of solubilizing the anti-cancer drug paclitaxel with up to 8 wt% loading.Entities:
Keywords: bioconjugation; drug delivery systems; elastin-like polypeptides; paclitaxel; ring-opening polymerization
Mesh:
Substances:
Year: 2016 PMID: 26756582 PMCID: PMC5320936 DOI: 10.1002/mabi.201500376
Source DB: PubMed Journal: Macromol Biosci ISSN: 1616-5187 Impact factor: 4.979